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Electrical stimulation of isolated muscles may lead to membrane
depolarization, gain of Na, loss of K and fatigue. These effects can
be counteracted with 2-agonists possibly via activation of the
Na-K pumps. Anoxia induces loss of force; however, it is not
known whether 2-agonists affect force and ion homeostasis in anoxic
muscles. In the present study isolated rat extensor digitorum longus
(EDL) muscles exposed to anoxia showed a considerable loss of force,
which was markedly reduced by the 2-agonists salbutamol (106 M)
and terbutaline (106 M). Intermittent stimulation (15–30 min) clearly
increased loss of force during anoxia and reduced force recovery
during reoxygenation. The 2-agonists salbutamol (107-105 M)
and salmeterol (106 M) improved force development during anoxia
(25%) and force recovery during reoxygenation (55–262%). The
effects of salbutamol on force recovery were prevented by blocking
the Na-K pumps with ouabain or by blocking glycolysis with
2-deoxyglucose. Dibutyryl cAMP (1 mM) or theophylline (1 mM)
also improved force recovery remarkably. In anoxic muscles, salbu-
tamol decreased intracellular Na and increased 86Rb uptake and K
content, indicating stimulation of the Na-K pumps. In fatigued
muscles salbutamol induced recovery of excitability. Thus 2-agonists
reduce the anoxia-induced loss of force, leading to partial force
recovery. These data strongly suggest that this effect is mediated by
cAMP stimulation of the Na-K pumps and that it is not related to
recovery of energy status (PCr, ATP, lactate).
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IT HAS BEEN KNOWN for over 60 years that adrenergic stimulation
increases the force production in fast-twitch mammalian skel-
etal muscle (6). However, the exact mechanism by which
2-agonists exert their effect on muscle force is still under
debate. 2-agonists bind to 2-adrenoreceptors, activating ad-
enylyl cyclase and thereby stimulating the conversion of ATP
to cAMP. This second messenger then activates protein kinase
A (PKA). PKA may phosphorylate a wide range of proteins
that may directly or indirectly increase force production. Sites
of action could be 1) the action potential, 2) excitation-con-
traction coupling or, 3) the myofilaments. Several studies have
addressed this question, and the effects of 2-agonists on force
production have been suggested to involve phosphorylation of
the ryanodine receptors, increasing Ca2-release from the SR
(8, 34), as well as phosphorylation of phospholemman
(FXYD1) (4), increasing the Na affinity of the Na-K
pumps, leading to increased pump activity (7, 16, 17).
Theophylline, which inhibits the phosphodiesterase degrad-
ing cAMP, thereby augmenting the intracellular concentration
of cAMP, has been shown to lead to hyperpolarization and
improved contractility of the diaphragm muscle both in vitro
and in vivo (2, 19) and to delay fatigue in human forearm
muscle during exercise (38). Other experiments on the human
forearm showed that the 2-agonist terbutaline induced an
increase in the net uptake of K (25). We previously explored
the mechanism of the stimulating effect of 2-adrenoceptor
agonists (salbutamol or epinephrine) on active Na-K trans-
port in detail (for review, see Ref. 14). In line with the in vivo
studies, we found that both salbutamol and the endogenous
2-agonist epinephrine stimulated 22Na efflux and 42K uptake
and induced hyperpolarization in isolated rat skeletal muscle at
concentrations down to 108 M (16). These effects were
blocked by ouabain and mimicked by cAMP or dibutyryl
cAMP. In addition, the effect of dibutyryl cAMP was amplified
by theophylline (17). In fatigued EDL muscle salbutamol was
shown to lead to a repolarization of the membrane potential
and a large increase in force recovery (39).
We previously showed that 15 min of intermittent stimula-
tion at 40 Hz (10 s on, 30 s off) leads to a marked decline in
force-generating ability of rat EDL muscle. One minute of
stimulation reduced force to below 80% of the initial force
(when tested using 500-ms trains of 1-ms pulses at 90 Hz and
12 V); however, full force recovery was obtained after 30 min
rest (40). If the duration of intermittent stimulation was in-
creased to 30 min force was reduced to below 10% of the initial
force, and the spontaneous recovery was reduced to 20% of
the initial force (39, 40). The causes of the observed fatigue are
not completely understood. It was evident, however, that the
membrane potential of muscles exposed to 30 min fatiguing
stimulation was depolarized compared with resting controls
(39). This suggests that the excitability of the muscles may be
compromised, leading to fewer action potentials being gener-
ated and propagated in the membrane during stimulation.
Hypoxia increases the rate of force decline, impairs force
recovery, and increases cell leakage (36, 48, 53). Additionally
we have shown that hypoxia or anoxia causes disturbances in
the cellular ion homeostasis (gain of cellular Ca2 and Na
with concomitant loss of K) and, when combined with intense
electrical stimulation, leads to cell leakage indicated by the
increased release of the intracellular enzyme, lactic acid dehy-
drogenase (LDH) (27). Studies in humans showed that when
hypoxia was induced by occlusion of circulation, the force of
the leg muscles was markedly decreased (32, 50). It has been
known for decades that hypoxia stimulates the sympathetic
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nervous system in healthy humans exposed to exercise during
hypoxia or to chronic hypoxia at high altitudes. This is evident
from increased plasma levels of norepinephrine and epineph-
rine above normoxic levels (10, 22). Therefore, it was inter-
esting to test the effects of 2-agonists on force in fatigued
muscles exposed to hypoxia. Previous studies on isolated
diaphragm muscle strips showed that following reduced avail-
ability of oxygen the rate of fatigue was increased and that this
was prevented by 2-agonists (salbutamol and salmeterol)
(52). The effects of 2-adrenoceptor agonists on force devel-
opment and recovery in skeletal muscle stimulated under
anoxia have not been investigated. Therefore in this study we
want to investigate 1) whether the 2-agonists and theophyl-
line, frequently used in the treatment of asthma, can improve
force in rat EDL muscles during or after exposure to anoxia,
and 2) whether this is due to an increase of excitability,
possibly caused by activation of the Na-K pumps.
During severe electrical stimulation or exposure to low
oxygen levels the energy status of the muscles might reach
critical low levels. We previously measured an 50% drop in
ATP and phosphocreatine (PCr) contents following 60 min of
intermittent stimulation in normoxic muscles (26). The same
study showed that when exposing muscles to electrical stimu-
lation and long-term anoxia (4 h) muscles were more or less
depleted of ATP (26). Others have shown that during occlusion
of circulation contraction of human leg muscles induced ex-
tensive drops in ATP (40%) and PCr (90%). However, 15 min
of recovery was enough to re-establish the levels of the
metabolites to almost normal levels (50, 51). Therefore in
addition, we want to test 3) whether the force loss/recovery is
dependent on metabolic energy status or excitability.
METHODS
Animals. All experiments were carried out using extensor digito-
rum longus (EDL) muscles prepared from 4-wk-old female and male
Wistar rats (own breed) weighing 60–70 g. Animals of this size were
chosen to obtain muscles small enough [maximum radius of 0.75 mm,
muscle weight of 20–25 mg and cross-sectional area (CSA) of
1.11–1.18 mm2] to allow diffusion of gas, ions, and substrates during
incubation. The maximum distance to which O2 can diffuse into an
isolated rat muscle in resting state at 30°C is 1.0 mm (3). The animals
had free access to food and water and were kept at constant temper-
ature (21° C) and day length (12 h).
No experiments were performed on live animals, and all handling
and use of animals complied with Danish animal welfare regulations,
including the euthanasia that in addition was approved by the Animal
Welfare Officer of Aarhus University.
Muscle preparation and incubation. The animals were killed by
cervical dislocation followed by decapitation, and intact EDL muscles
were dissected out as previously described (13). The standard incu-
bation medium was a Krebs-Ringer (KR) bicarbonate buffer (pH 7.3)
containing (in mM): 122.1 NaCl, 25.1 NaHCO3, 2.8 KCl, 1.2
KH2PO4, 1.2 MgSO4, 1.3 CaCl2 and 5.0 D-glucose. Incubation took
place at 30°C in a volume of either 5 or 8 ml. The buffer was
continuously gassed with a mixture of 95% O2 or N2 and 5% CO2.
After preparation, the muscles were mounted at resting length in force
transducers between platinum wire electrodes, allowing measurement
of isometric contractions. They were equilibrated with a mixture of
95% O2 and 5% CO2 in the standard medium for 30 min before
further treatment. This procedure has been shown to allow the main-
tenance of constant force, K, Na, and Ca2 contents for several
hours in vitro (23, 26, 39). In the present paper we investigated the
effect of incubation for up to 240 min with test of force at 90 Hz
(using 500-ms trains of 0.2-ms pulses at 12 V) every 20 min on
muscle PCr, ATP, and lactate contents. As shown in Fig. 1 these
metabolic values stayed constant.
Anoxic conditions. After equilibration for 30 min in oxygenated
KR, the muscles were incubated in buffer pregassed (30 min) with
95% N2 and 5% CO2. When exposed to 95% N2/5% CO2 for 10 -15
min the oxygen tension in the buffer was shown to be 0 kPa and the
condition is therefore referred to as anoxic. In all experiments, except
those included in Fig. 1, muscles were exposed to anoxia during the
period of fatiguing stimulation and reoxygenated during the recovery
period. In experiments where muscles were resting and tested elec-
trically only every 20 min (Fig. 2), muscles were exposed to anoxia
throughout the experiment.
Electrical stimulation. A previously developed standard fatiguing
stimulation protocol was applied in the stimulation experiments (40).
Muscles were stimulated intermittently for 15 or 30 min (10 s on, 30
s off) at 40 Hz (0.2 ms pulses, 12 V). Stimulation was applied through
two fine platinum wire electrodes that transversed the muscle (4 mm
apart) on either side of the central part of the muscle [as described in
Cairns et al. (9)].
Force measurement. The experimental set-up used for force mea-
surements allowed for the simultaneous recordings from four muscles
in separate incubation chambers containing 8 ml buffer. EDL muscles
were mounted in force transducers (Grass FTO3, W. Warwick, RI)
and during repeated stimulation with single pulses adjusted to optimal
length for twitch force development. Force was recorded with a
PowerLab data acquisition system (ADI instruments, Australia). Prior
to intermittent stimulation, all four muscles were tested at 90 Hz (0.2
ms pulses, 12 V) for 500 ms to achieve maximum tetanic activation of
all muscle fibers. Testing was done three times at 15-min intervals
before the fatiguing stimulation. Maximum force at 90 Hz was
between 40 and 50 g (392–491 mN), hence maximum force per CSA
in these muscles was 35–42 N/cm2. These values are in good
agreement with other studies on rat EDL muscles [e.g., 59 N/cm2 at
36 °C (1); 27 N/cm2 at 25 °C (33)]. Muscles were hereafter fatigued
for 15 or 30 min using the 40-Hz intermittent stimulation protocol.
Force was recorded during the fatiguing stimulation. The initial
absolute force at 40 Hz was 14–26 g (137–255 mN) in the normoxic
muscles and 11–22 g (108–216 mN) in the anoxic muscles. In the
recovery period following stimulation, muscles were tested at 90 Hz
Fig. 1. PCr, ATP, and lactate contents. Effect of long-term incubation during
normoxia. Rat extensor digitorum longus (EDL) muscles were mounted in
force displacement transducers, and isometric force was tested at 90 Hz (using
500-ms trains of 0.2-ms pulses at 12 V) every 20 min for up to 240 min under
oxygenated conditions. Values are means of 4 muscles with error bars
indicating SE.
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(using 500-ms trains of 0.2-ms pulses at 12 V) every 20 min and
compared with force prior to fatiguing stimulation.
Excitability. Muscles were incubated with tubocurarine (105 M)
to avoid nerve interference and tested at 2 Hz (600-ms pulse trains, 12
V) at increasing pulse durations (0.02, 0.1, 0.3, 0.5, 0.7, 0.9, and 1.1
ms) prior to the anoxic fatiguing protocol and following 150 min of
reoxygenation  salbutamol (105 M).
Inhibition of glycolysis. Muscles were incubated in glucose-free
Krebs Ringer buffer with the glucose analog 2-deoxyglucose (10
mM). Insulin (10 mU/ml) was added to the solution to ensure
sufficient intracellular accumulation of 2-deoxyglucose to inhibit
glycolysis (42).
Intracellular Na and K contents. At the end of the experiments,
muscles were transferred to ice-cold Na-free Tris-sucrose buffer and
underwent 4  15 min wash-out to remove extracellular Na. The
Na-free Tris-sucrose had the following composition (in mM): 263
sucrose, 10 Tris·HCl, 2.8 KCl, 1.3 CaCl2, 1.2 MgSO4, 1.2 KH2PO4
(pH 7.4). Following wash-out, the tendons were removed and the
muscles were blotted, weighed, and soaked overnight in 3 ml 0.3 M
trichloroacetic acid (TCA) to extract ions from the tissue. Previous
studies showed that this procedure is as efficient in extraction of ions
as homogenization and subsequent centrifugation of the TCA extract
(28, 29). Na and K contents of the TCA extracts were determined
using a Radiometer FLM3 flame photometer (Copenhagen, Denmark)
with lithium as the internal standard. For each 0.5-ml sample of the TCA
extract, 1.5 ml of 5 mM LiCl and 0.5 ml of 0.3 M TCA were added.
Previous experiments have shown that part of the intracellular Na is lost
during the 4  15 min wash-out at 0°C (24). This loss of Na was
corrected by multiplying with a correction factor of 1.59 (43).
86Rb uptake. 86Rb has been shown to be a reliable tracer for deter-
mination of Na-K pump-mediated K transport (14). To investi-
gate the effects of salbutamol on 86Rb uptake, muscles were incubated
in KR containing 86Rb (0.1 Ci/ml; and tubocurarine 105 M to avoid
nerve interference) without or with salbutamol (106 M) for 60 min.
This was followed by 4  15 min ice-cold wash-out in Na-free
Tris-sucrose buffer to remove extracellular 86Rb. Finally, muscles
were blotted, tendons cut off, muscle wet weight determined, and then
muscles were soaked in 3 ml 0.3 M TCA. The next day, 86Rb activity
of the TCA extract was determined by measuring Cerenkov radiation
in a scintillation counter.
Measurements of PCr, ATP, and lactate contents. Muscles were
frozen and later freeze-dried, dissected free of non-muscle tissue, and
powdered. Extracts were analyzed for PCr, ATP, lactate, and creatine
(Cr), as previously described (35). To adjust for variability in solid
nonmuscle constituents and weighing variability, values were normal-
ized by dividing by the total amount of creatine (PCr  Cr) and
multiplied by the mean of total creatine for the whole material [116.3
mmol/kg dry muscle (46)].
LDH release. As an indicator of cellular integrity, the release of
LDH from the muscles into the incubation medium was determined as
previously described (29). In short, after being mounted on muscle
holders in 5-ml chambers, but prior to measurement, the muscles were
prewashed 4  30 min to remove LDH released from cells damaged
during excision of the muscles. Buffer samples for determination of
the level of LDH release before the fatiguing stimulation were taken
from the last of the prewash tubes. During recovery, after the fatiguing
stimulation, the muscles were moved to new tubes every 30 min.
Buffer samples were taken immediately after removal of the muscle,
and bovine serum albumin (BSA) was added to a final concentration
of 0.1%. A 100-l sample was mixed with 900 l phosphate buffer
(0.1 M K2HPO4 titrated with KH2PO4 to pH 7.0) containing NADH
(0.3 mM) and pyruvate (0.8 mM), and the decline in the absorbance
of the substrate NADH was monitored at 340 nm (Perkin Elmer,
Lambda 20) at 30°C. The activity of LDH was expressed as units per
gram muscle wet weight per 30 min, 1 unit (U) being the amount of
enzyme that catalyzes the utilization of 1 mol substrate/min. The
total amount of LDH in EDL muscles from 4-wk-old rats was
previously determined to be 585  13 U/g wet wt (29).
Chemicals. All chemicals were of analytic grade. Salbutamol,
salmeterol, terbutaline, theophylline, tubocurarine, db-cAMP, ICI
188.551, and ouabain were purchased from Sigma (St. Louis, MO).
Fig. 2. A and B: force and metabolite content in rat EDL muscle exposed to
anoxia. Effects of salbutamol (106 M) or terbutaline (106 M). Rat EDL
muscles were mounted in force displacement transducers, and isometric force
was tested at 90 Hz (using 500-ms trains of 0.2-ms pulses at 12 V) under
oxygenated conditions. Twenty minutes after gas was changed to 95% N2 and
5% CO2, force was tested at 90 Hz every 20 min for 180 min. Tubocurarine
(105 M) was present 40 min prior to anoxia and throughout the experiment.
At incubation time  0 (20 min into anoxia) salbutamol (106 M) (Œ) or
terbutaline (106 M) (□) were added (terbutaline only in A). Muscles were
incubated in anoxia during the entire experiment. A: values are means in
percent of the force measured prior to addition of compounds, with error bars
indicating 2 SE. Anoxic controls and salbutamol-treated anoxic muscles: N
 6. Terbutaline-treated anoxic muscles: N  4. Significant differences
between the anoxic controls () and the salbutamol-treated anoxic muscles are
denoted by *(P 	 0.05) and ***(P 	 0.001) and between anoxic controls and
terbutaline-treated anoxic muscles: ¤¤¤(P 	 0.001). B: PCr, ATP, and lactate
content in normoxic control muscles and in muscles exposed to 80 min of
anoxia salbutamol (106 M) for 60 min. Values are means of 4 muscles with
error bars indicating SE. Significant differences within groups between con-
trols and anoxic muscles are denoted by ***P 	 0.001 (PCr), ¤¤¤P 	 0.001
(lactate).
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NADH and pyruvate were purchased from Boehringer-Mannheim
(Mannheim, Germany).
Statistics. Statistical comparisons were made using ANOVA. In
cases in which the F ratio from the ANOVA was significant (P 	
0.05), an additional post hoc test (Bonferroni) was performed to
search for differences among interventions (i.e., oxygenation, electri-
cal stimulation, drug treatments, and time). The significance of dif-
ferences among groups assigned from this test is denoted by P values.
All values are given as mean with SE.
RESULTS
To test the effect of anoxia on EDL, resting muscles were
exposed to anoxia for 200 min and force was tested at 90 Hz
every 20 min. Twenty minutes into anoxia muscles were
treated with the 2-agonists salbutamol or terbutaline. As
shown in Fig. 2A salbutamol (106 M) or terbutaline (106 M)
prevented the immediate loss of force, and after 1 h of incu-
bation force was still above 80%. However, after 2 h of
incubation, force in the muscles exposed to salbutamol or
terbutaline was just as low as in the anoxic control muscles (or
even lower in the salbutamol-treated muscles). Figure 2B
shows the contents of PCr, ATP, and lactate in these anoxic
muscles. For comparison, the contents in normoxic control
muscles are shown. The data show that ATP content was kept
constant despite 80 min of anoxia, whereas the content of PCr
was reduced by 67% (P 	 0.001) during this period. Lactate
was increased by 2,400% (P 	 0.001). Treatment with salbu-
tamol induced no significant changes. As shown in Table 1,
anoxia increased Na content by 37% and decreased K
content by 16%. During anoxia, salbutamol normalized Na
content and induced partial recovery of K content. In line
with this, salbutamol treatment of anoxic muscles increased
86Rb uptake by 12% [from 549  20 (N  11) to 614  19
(N  9) nmol·g wet wt1·min1; P 	 0.05] measured during
60 min of exposure to anoxia, indicating increased activity of
the Na-K pumps.
To test the effect of salbutamol under more severe condi-
tions, muscles were exposed to intense stimulation (10 s on, 30
s off, 40 Hz) under anoxia. Due to a rapid force loss, stimu-
lation and anoxia was limited to 15 or 30 min. In some of these
experiments salbutamol at a concentration of 105 M was used
to ascertain maximum effect of the drug. No significant differ-
ence was found in force between normoxic and anoxic muscles
during the 90-Hz test stimulation done at the beginning of the
experiment during oxygenated conditions [425 20 vs. 443
12 mN for normoxic and anoxic muscles, respectively (P 
0.41)]. Figure 3A shows absolute force during 15 min of
intermittent electrical stimulation during both normoxia and
anoxia and the effect of salbutamol under both conditions.
There is a slight tendency to a reduced force in the anoxic
muscles during the first 40-Hz pulse train, however, this was
not significant [207  37 vs. 168  17 mN for normoxic and
anoxic muscles, respectively (P  0.30)]. Treatment with
salbutamol (105 M) 15 min prior to the fatiguing protocol (15
min of intermittent 40-Hz stimulation under normoxia or an-
oxia) had no significant effect in the normoxic muscles but
augmented force in the anoxic muscles by 25% (P 	 0.001),
reaching the level of the oxygenated controls (Fig. 3A). How-
ever, after 3 min of stimulation this effect was no longer
observed. In the normoxic muscles, the fatiguing protocol
induced a long lasting force impairment (reaching max 40% of
initial force) and addition of salbutamol had no effect on force
recovery (data not shown). Figure 3B shows force recovery in
the anoxic muscles in the following reoxygenation period.
Both the anoxic controls and the salbutamol-treated muscles
showed recovery within the first 20 min. In the control group, no
further recovery was observed, whereas in the salbutamol-treated
group force kept increasing to 60% above control (P 	 0.05)
and remained elevated for the duration of the experiment. Mea-
surements of intracellular Na content showed a significantly
reduction in the salbutamol-treated muscles after 180 min of
reoxygenation compared with the anoxic control muscles (11.0
1.0 vs. 14.2  1.1 mol/g wet wt, P 	 0.05, N  8).
In separate experiments, the effect of the slower, but longer
acting, 2-agonist salmeterol (106 M) added 15 min prior to the
anoxic stimulation protocol, was tested as described in the legend
to Fig. 3, A and B. Salmeterol induced almost the same effects
on force as salbutamol. Again force was significantly improved
initially during the stimulation protocol (P 	 0.001), and force
recovered to 40% above the level of the controls
(P 	 0.05–0.01, N  8; data not shown) in the reoxygenation
period.
Figure 4 shows the force recovery in the reoxygenation
period in muscles that had either been resting or exposed to
intermittent electrical stimulation for 15 min during the pre-
ceding anoxic period. Immediately after anoxia, force in the
muscles that had been resting was reduced to 80% of initial
force. However, force recovered back to the initial level within
20 min. Addition of salbutamol 150 min into the reoxygenation
period caused no further improvement of force. In contrast, in
muscles that had been given intermittent stimulation in anoxia,
force was reduced to only 10% immediately after the anoxic
period. During reoxygenation force spontaneously recovered to
a level around 30% within the first 20–40 min. Addition of
salbutamol (105 M) 150 min into the reoxygenation period
improved force recovery by 102  16% compared with con-
trols (P 	 0.001), reaching 55–60% of the preanoxic level.
Force stayed significantly increased for the remaining part of
the experiment. Intracellular Na content was measured at 180
or 240 min of reoxygenation. At 180 min, 30 min after addition
of salbutamol (105 M), a minor and nonsignificant reduction
in intracellular Na was observed (from 14.2  1.5 to 12.1 
Table 1. Intracellular Na and K content
Treatment Na, mol/g wet wt K, mol/g wet wt
Normoxic controls 9.8 0.6 (4) 104.7  0.9 (4)
Anoxic controls 13.4 0.6 (11) 87.9  0.9 (11)
†P 	 0.01 †P 	 0.001
Anoxia salbutamol 9.2 0.5 (9) 93.2  1.0 (9)
*P 	 0.001 *P 	 0.001
‡P  0.534 ‡P 	 0.001
Values are means SE with the number of muscles in parentheses. Muscles
were exposed to normoxia or anoxia for 80 min and tested using 500-ms trains
of 0.2-ms pulses at 90 Hz and 12 V every 20 min. Salbutamol (106 M) was
added after 20 min of anoxia. At the end of the experiment, muscles were
transferred to ice-cold Na-free Tris-sucrose buffer and underwent 415 min
wash-out to remove extracellular Na. Following wash-out, the tendons were
removed, and the muscles were blotted, weighed, and soaked overnight in 3 ml
0.3 M TCA to extract ions from the tissue. See METHODS for further descrip-
tions. Significance of differences between normoxic controls and anoxic controls
are denoted by †P values. The significance of differences between anoxic
controls and salbutamol-treated anoxic muscles are denoted by *P values. P
values for the difference between normoxic controls and salbutamol-treated
anoxic muscles are denoted by ‡.
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1.2 mol/g wet wt, P  0.3, N  13). However, at 240 min,
90 min after the addition of salbutamol, intracellular Na
showed a considerably larger and significant decrease (from
16.4  1.2 to 8.9  0.6 mol/g wet wt, P 	 0.001, N  11).
To investigate whether the effect of salbutamol could be
observed in even more fatigued muscles, the duration of
stimulation was increased to 30 min (40 Hz, 10 s on, 30 s off
under anoxia). As shown in Fig. 5A force immediately after the
anoxic period was only2% of initial force, which is one-fifth
of that observed in muscles exposed to only 15 min of stimu-
lation. Thereafter force increased spontaneously to 10%.
Salbutamol (107 or 105 M) added 90 min into reoxygenation
improved force recovery significantly (at 200 min into reoxy-
genation) by 78% (107 M) and 116% (105 M), respectively
(P 	 0.001 for both groups), compared with the reoxygenated
controls. The relative increase in force in the salbutamol-
treated muscles (force at 200 min compared with force in the
same group just prior to addition of salbutamol) was 55%
(107 M) and 262% (105 M), respectively (P 	 0.001 for
both groups). Figure 5B shows the effect of anoxia and reoxy-
genation on energy status of the muscles. Thirty minutes of
stimulation during anoxia induced severe reduction in both PCr
and ATP contents (to 7% and 19% of controls, respectively,
P 	 0.001). Concurrently a tremendous increase in lactate was
observed (4,200% of control). Following 80 min of reoxygen-
ation PCr and ATP had recovered to 61% and 47% of controls,
respectively, and lactate was completely normalized. Further
reoxygenation did not induce any effect on metabolite status,
neither did the addition of salbutamol (106 M) at 90 min into
reoxygenation (last column).
As a control experiment, the specificity of salbutamol acting
via the 2-adrenoceptor was tested using the selective 2-
antagonist ICI 118.551 (105 M). Preincubation with ICI
118.551 20 min prior to addition of salbutamol (107 M)
completely abolished the salbutamol-induced force recovery
(Table 2).
Fig. 3. A: force during normoxia or anoxia. Effects of salbutamol (105 M)
added prior to stimulation. EDL muscles were exposed to normoxia or anoxia
from the onset of 15-min intermittent electrical stimulation (40 Hz, 10 s on, 30
s off, 0.2-ms pulses). Salbutamol (105 M) was added 15 min prior to
stimulation to one group (open symbols). Absolute force is given in mN.
Values are means with error bars indicating SE. Œ: normoxic controls (N  3);
o: salbutamol-treated normoxic muscles (N  4); : anoxic controls (N  7);
Œ: salbutamol-treated anoxic muscles (N 7). Significant differences between
anoxic controls and salbutamol-treated anoxic muscles are denoted by **(P 	
0.01) and ***(P 	 0.001). B: force recovery during reoxygenation following
stimulation during anoxia. Effects of salbutamol (105 M) added prior to
stimulation. Force recovery during reoxygenation (tested using 500-ms trains
of 0.2-ms pulses at 90 Hz and 12 V every 20 min) following 15-min
intermittent electrical stimulation (40 Hz, 10 s on, 30 s off, 0.2-ms pulses)
during anoxia. Values are means in percent of the force measured prior to
anoxia with error bars indicating SE. : anoxic controls; Œ: salbutamol-treated
anoxic muscles. N  7 muscles in each group. Significant differences between
anoxic controls and salbutamol-treated anoxic muscles are denoted by *(P 	
0.05).
Fig. 4. Force recovery during reoxygenation following stimulation during
anoxia. Effects of salbutamol (105 M) added 150 min into reoxygenation.
Force recovery during reoxygenation (tested using 500-ms trains of 0.2-ms
pulses at 90 Hz and 12 V every 20 min) following 15 min of rest or 15-min
intermittent electrical stimulation (40 Hz, 10 s on, 30 s off, 0.2-ms pulses)
during anoxia. Values are means in percent of the force measured prior to
anoxia with error bars indicating 2 SE. Resting muscles: triangles (N  4
muscles). Stimulated muscles: circles (N  12 muscles). Open symbols
represent muscles treated with salbutamol (105 M). Significant differences
between the control group and the group treated with salbutamol are denoted
by ***(P 	 0.001).
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Effects of cAMP and theophylline. The role of cAMP in force
recovery was examined by incubating muscles with theophylline,
which reduces the degradation of cAMP, thus increasing intracel-
lular cAMP. As shown in Fig. 6, theophylline alone (1 mM)
significantly increased force recovery. The combination of salbu-
tamol (107 M) and theophylline (1 mM) did not cause further
increase in force recovery (Table 2).
In other experiments, the direct effect of cAMP on force
recovery was tested. This was done by incubating muscles with
the dibutyryl-derivative of cAMP (db-cAMP), which gains
access to the cytoplasm more rapidly than cAMP. Db-cAMP (1
mM) acted slower than salbutamol and theophylline but im-
proved force recovery significantly by 75% (P 	 0.05). The
relative increase in force in the db-cAMP-treated muscles [200
min compared with the force just prior to addition of db-cAMP
(80 min)] was 109% (P 	 0.01; N  5–9 muscles, data not
shown).
Excitability. To test whether the force recovery observed
with salbutamol was due to an increase in excitability of the
fibers, force was tested at 2 Hz with pulse durations ranging
from 0.02 to 1.1 ms. Tubocurarine (105 M) was present
throughout the experiment to block out any effect from the
nerve. Thus 0.02-ms pulses normally leading to stimulation via
the nerve did not result in any force production. The test was
performed before the 15 min fatiguing stimulation (controls)
and 150 min into recovery  salbutamol (105 M).
Figure 7A shows force in each group relative to force
measured at a pulse duration of 1.1 ms. At a pulse duration
of 1.1 ms, all excitable fibers are expected to be excited. As
pulse duration is reduced the least excitable fibers fail to
activate, resulting in reduced force. Thus this graph illus-
trates the excitability of the muscles. Prior to the fatiguing
stimulation, pulse duration could be reduced to 0.3 ms
without any marked loss of force. After fatiguing stimula-
tion during anoxia, force during reoxygenation was signif-
icantly reduced at 0.3- and 0.1-ms pulses. Salbutamol re-
covered excitability with the muscles showing the same
pattern of force loss as the controls.
Figure 7B shows force relative to force prior to stimulation
(controls) measured at a pulse duration of 1.1 ms, thus allowing
comparison of force between groups. Following fatiguing stim-
ulation during anoxia, force is reduced to 10% of the control
level at all pulse durations from 0.3 ms and above. Salbutamol
improves force recovery by 200%, reaching 30% of the
control level from 0.3 ms and above.
Membrane integrity. To investigate whether cellular in-
tegrity was lost, release of the intracellular enzyme LDH to
the buffer was measured in the reoxygenation period. Fif-
teen-minute stimulation in anoxia caused no significant
increase in the release of LDH either without (from 0.14 
0.02 to 0.43  0.10 U·g muscle wet wt1·30 min1, N  3,
P  0.13) or with salbutamol (from 0.24  0.01 to 0.68 
0.18 U·g muscle wet wt1·30 min1, N  3, P  0.15),
indicating that membrane integrity was preserved and that
treatment with salbutamol had no deleterious effect on
muscle integrity. However, following 30 min stimulation in
anoxia a significant increase in LDH release was observed
(from 0.42  0.12 to 6.23  1.35 U·g muscle wet wt1·30
min1, N  3, P 	 0.05), indicating loss of cellular integrity
under these conditions. The effect of salbutamol was not
tested at this time point. However, we previously showed
that salbutamol has no effect on the release of LDH in
severely damaged muscles (39).
Effects of ouabain and 2-deoxyglucose. When muscles were
incubated with ouabain (103 M), a blocker of the Na-K
pump, force was completely abolished in all muscles and no
effect of salbutamol (105 M) on force could be detected (data
not shown). To investigate whether inhibition of glycolysis and
thereby also aerobic metabolism is important for the salbuta-
mol-induced improvement of force, muscles were incubated in
glucose-free KR with 2-deoxyglucose (10 mM) and insulin (10
mU/ml, to stimulate the intracellular accumulation of 2-deoxy-
glucose) during reoxygenation (40). Whereas muscles exposed
to salbutamol in normal KR showed a marked and highly
significant increase in force as shown in Fig. 4, the muscles
with 2-deoxyglucose  insulin showed no response to salbu-
tamol, but rather a minor decrease in force compared with
controls without salbutamol (15  6%, N  6; data not
shown).
DISCUSSION AND CONCLUSIONS
The main findings of the present study are that 2-agonists
(salbutamol, terbutaline, and salmeterol) can improve force
during and following anoxia. This effect seems to be mediated
by cAMP and to involve stimulation of the Na-K pumps and
recovery of membrane potential and excitability. The salbuta-
mol-induced force recovery is not related to the energy status
of the muscle (Fig. 5B).
Exposure to anoxia induces a decline in force, which can be
postponed by salbutamol (106 M) or terbutaline (106 M)
(Fig. 2A). The explanation for the initial improvement of force
before alterations in ion gradients (Table 1) might be that
repolarization of the membrane potential due to the electro-
genic action of the Na-K pumps is expected to occur before
changes in bulk Na can be observed. On the other hand,
studies suggest that the 2-agonist-induced increase in cAMP
stimulates the SR Ca2 pump, increasing the concentration of
Ca2 within the SR (7, 34). We cannot exclude that this extra
Ca2 might produce the increase in tension in the early phase
Fig. 5. A: force recovery during reoxygenation following stimulation during anoxia. Effects of salbutamol (107 and 105 M) added 90 min into reoxygenation.
Force recovery during reoxygenation (tested using 500-ms trains of 0.2-ms pulses at 90 Hz and 12 V every 20 min) following 30 min of intermittent electrical
stimulation (40 Hz, 10 s on, 30 s off, 0.2-ms pulses) during anoxia. Values are means in percent of the force measured prior to anoxia with error bars indicating
SE. : controls (N  10 muscles); □: muscles treated with salbutamol 107 M (N  11 muscles); Œ: muscles treated with salbutamol (105 M) at 90 min (N 
4 muscles). Significant differences between control group and group treated with salbutamol (107 M) are denoted by ***(P 	 0.001) and differences between
control group and group treated with salbutamol (105 M) are denoted by ¤¤(P 	 0.01) or ¤¤¤(P 	 0.001). B: PCr, ATP, and lactate contents. Effect of anoxia,
reoxygenation, and salbutamol (106 M). PCr, ATP, and lactate contents in normoxic control muscles and in muscles exposed to 30 min of intermittent electrical
stimulation (40 Hz, 10 s on, 30 s off, 0.2-ms pulses) in anoxia followed by 200-min reoxygenation  salbutamol 106 M added at 90 min into the reoxygenation
period. Values are means of 4 muscles with error bars indicating SE. Significant differences from control muscles are denoted by ***P 	 0.001 (PCr), $$$P 	
0.001 (ATP), ¤¤¤P 	 0.001 (lactate).
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in Fig. 2A. In more fatigued muscles, where anoxia is com-
bined with intermittent electrical stimulation, force declines
rapidly, and a long-lasting force impairment, even during
reoxygenation, is observed. Also in this situation, as during the
early phase of anoxia discussed above, initial force is clearly
improved by salbutamol (Fig. 3A) or salmeterol. During nor-
moxia force declines less rapidly but still a long-lasting force
impairment is observed in the following recovery period.
Addition of salbutamol does not improve force significantly in
the normoxic muscles (Fig. 3A). This might seem controversial
as we previously showed that fatiguing stimulation during
normoxia induced a long-lasting force impairment during re-
covery, which could be reduced by the addition of salbutamol
(105 M) (39). However, in that study muscles were severely
fatigued during a 30-min intermittent electrical protocol, in
contrast to the shorter period of only 15 min in the present
study. Thus the beneficial effect of salbutamol is only evident
when muscles are severely fatigued during normoxia or ex-
posed to anoxia.
Indeed after 30 min of stimulation under anoxia, where
muscles are severely fatigued, salbutamol (105 M and 107
M) markedly improves force recovery (Fig. 5A).
In the present study we confirmed the 2-receptor speci-
ficity of salbutamol by showing that in muscles preincubated
with a well-established 2-receptor antagonist, ICI 118.551
(41, 44), salbutamol-induced improvement of force was
completely abolished. The importance of cAMP in anoxic
muscles was investigated in two experiments: first by re-
ducing the degradation of cytosolic cAMP by theophylline
(1 mM) and second by incubating muscles with db-cAMP (1
mM), which readily gains access to the cytoplasm. In both
Table 2. Force recovery in muscles following stimulation
during anoxia
Treatment
Force (% of initial)
50 min after addition
of compounds P N
Controls 10.2  1.3 10
Salbutamol (107 M) 20.7  1.9 	0.001 11
Salbutamol (105 M) 24.2  3.6 	0.001 4
Theophylline (1 mM) 18.7  1.8 	0.01 7
Theophylline (1 mM) 
salbutamol (107 M) 23.7  1.7 	0.001 8
ICI 118.551 (105 M) 
salbutamol (107 M) 13.0  0.9 NS 3
Values are means  SE of N muscles in percent of the force measured prior
to anoxia. Muscles were electrically stimulated (40 Hz, 10 s on, 30 s off,
0.2-ms pulses) during anoxia for 30 min. Then force recovery was followed
during reoxygenation (tested using 500-ms trains of 0.2-ms pulses at 90 Hz and
12 V every 20 min). 90 min into the recovery period, the specific 2-antagonist
ICI 118.551, salbutamol and/or theophylline were added as indicated. Force
was measured 50 min after (at 140 min into recovery) and compared with force
prior to the fatiguing stimulation. Some data are taken from Figs. 4 and 5 to
compare effects.
Fig. 6. Force recovery during reoxygenation. Effects of theophylline (1 mM) 
salbutamol (107 M) added 90 min into reoxygenation. Force recovery during
reoxygenation (tested using 500-ms trains of 0.2-ms pulses at 90 Hz and 12 V
every 20 min) following 30 min of intermittent electrical stimulation (40 Hz, 10 s
on, 30 s off, 0.2-ms pulses) during anoxia. Values are means in percent of the force
measured prior to anoxia with error bars indicating SE. : controls (N  10
muscles); Œ: muscles treated with theophylline (1 mM) alone (N  7 muscles);
□: muscles treated with theophylline (1 mM) and salbutamol (107 M)
(N 8 muscles). Significant differences between control group and group treated
with theophylline are denoted by §§(P 	 0.01). Significant differences between
control group and group treated with theophylline and salbutamol are denoted by
***(P 	 0.001).
Fig. 7. A and B: force at different pulse durations following reoxygenation.
Effects of salbutamol (105 M). Force tested at different pulse durations (0.02,
0.1, 0.3, 0.5, 0.7, 0.9, and 1.1 ms) at 2 Hz, supramaximal voltage (12 V) prior
to 15 min of intermittent stimulation (40 Hz, 10 s on, 30 s off, 0.2-ms pulses)
during anoxia (controls) and 150 min into reoxygenation  salbutamol (105
M) added at 90 min into reoxygenation. A: values are means in per cent of the
force measured using 1.1-ms pulses after anoxia with error bars indicating SE.
B: values are means in percent of the force measured using 1.1-ms pulses prior
to anoxia with error bars indicating SE. A and B: : controls (prior to
stimulation during anoxia) (N  6 muscles); : 150 min into reoxygenation
(N 3 muscles); □: 150 min into reoxygenation salbutamol (105 M) at 90
min (N 3 muscles). Significant differences between anoxic group and anoxic
group treated with salbutamol are denoted by **(P 	 0.01) and ***(P 	
0.001).
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cases, force recovery was significantly improved. Thus
increasing the availability of cAMP improves force recovery
following stimulation under anoxia. The same has been
observed for muscles fatigued under normoxic conditions
(39). The severe anoxic protocol we apply induces massive
reduction in PCr and ATP, in accordance with previous
studies in anoxic human muscles (32, 50, 51). However, the
metabolite levels in these severely depleted rat muscles can
recover up to 75% within 200 min of reoxygenation. No
effect of salbutamol was observed on metabolite levels (Fig.
5B). Since force recovers up to only 10% in control muscles
and salbutamol improves this recovery to 20 –25% of initial
level (Fig. 5A), the improvement of force induced by sal-
butamol is apparently not caused by augmented energy
status of the muscle.
Impaired excitability has been proposed as an important
contributor to severe fatigue (9). In this study we found that
excitability was reduced following the anoxic stimulation
protocol (evidenced as lower force production at shorter
pulse lengths, Fig. 7A). Treatment with salbutamol com-
pletely recovered excitability of the muscle. Several factors
may be involved in recovery of excitability but stimulation
of the Na-K pumps is a likely candidate. Increased
pumping would lead to recovery of the ion gradients and
repolarization of the membrane. The observation that treat-
ment of resting anoxic muscles with salbutamol returns Na
content back to normal (Table 1) and at the same time
increases 86Rb uptake clearly indicates that salbutamol in-
creases Na-K pump activity, in keeping with many ear-
lier studies (14). Thus the anoxia-induced force deficit may
largely be explained by a loss of excitability, as indicated by
the impressive recovery of force in salbutamol-treated mus-
cles. However, a large force deficit still remains. This must
be ascribed to factors acting downstream from excitability
and could involve impaired SR Ca2 release or structural
damage within the muscle fiber.
When glycolysis was inhibited due to the presence of
2-deoxyglucose, no effect of salbutamol could be observed.
An important point is that the effect of salbutamol on force
is not suppressed by anoxia, but is indeed by 2-deoxyglu-
cose. This emphasizes the importance of glycolytic ATP for
the salbutamol-induced force recovery. In vascular smooth
muscle (47) and in cardiac Purkinje cells (30) glycolysis has
been shown to preferentially provide ATP for the Na-K
pumps. When glycolytic ATP supply in skeletal muscle was
inhibited with 2-deoxyglucose, Na-K pump activity was
shown to be reduced (20, 45).
As previously shown (27), membrane damage was ob-
served in muscles exposed to 30 min of stimulation in
anoxia, suggesting that this might be responsible for part of
the observed force loss. It should be mentioned that during
that experiment only a modest fraction of the total LDH
content was released from the muscles. The cumulated
release of LDH from the muscles at the end of the experi-
ment was 35 U/g wet wt, amounting only to 6% of their total
LDH content (29). In contrast, we did not find significant
changes in membrane leakage following 15 min of anoxic
stimulation. Importantly, even in the damaged muscles sal-
butamol can recover force, indicating that stimulation of the
electrogenic Na-K pumps in the remaining intact sarco-
lemma might be sufficient to partly restore excitability in
these muscles.
Salmeterol acts slower but with a longer duration than
salbutamol (52). Earlier observations in this laboratory
showed that the two 2-agonists reduced intracellular Na
content in rat soleus muscle to the same level. However, the
effect of salmeterol was 4.5 times slower than that of
salbutamol (unpublished data). In the present study both
salbutamol and salmeterol improved force initially during
the anoxic stimulation protocol (preincubation time was 15
min for both). During recovery the effect of salmeterol was
smaller and later in onset than that of salbutamol.
2-agonists are widely used to improve respiration in
asthmatic patients. These patients are exposed to shorter or
longer periods of hypoxia during asthmatic attacks. 2-
agonists are also widely used by athletes, where asthma
prevalence is high. Concerns have been raised regarding the
potential competitive advantage provided by these drugs.
Investigations of the possible ergogenic effect of 2-
agonists are many, but the results are inconsistent. Signorile
et al. (49) suggest an ergogenic effect of acute inhalation of
albuterol (US name for salbutamol) on power output on a
cycle ergometer, and Caruso et al. (12) showed that thera-
peutic doses of albuterol augmented strength during resis-
tance exercise. In contrast, Decorte et al. (18) recently found
no effect of acute inhalation of salbutamol on quadriceps
strength, fatigue, and recovery in men without asthma. Oral
administration of salbutamol, in contrast to inhaled 2-
agonists, might improve muscle strength and performance
(37). When infused at a higher dosage than used clinically
for treatment of respiratory emergencies, salbutamol has
been shown to increase the contractility in respiratory mus-
cles of awake healthy canines by 58% (21).
Patients with lung diseases (e.g., COPD) complain of leg
fatigue and exercise intolerance due to peripheral muscle dysfunc-
tion (5, 11, 31). Treatment with salmeterol has recently been
shown to improve leg muscle performance in COPD patients (5).
Thus, by taking salbutamol or salmeterol as bronchodilators, these
patients might experience a further beneficial effect during daily
muscle work.
The present study provides new information about the ben-
eficial effects of salbutamol on force production in isolated rat
muscles during an anoxic period and on force recovery during
a subsequent reoxygenation period. The results support the
idea that the Na-K pumps are involved in the restoration of
the Na and K homeostasis and membrane excitability,
thereby improving force recovery. This could be important
for the performance of limb muscles or diaphragm during or
after the periods of hypoxia that occur in patients with, e.g.,
asthma or COPD.
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